GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioNxt Solutions Inc (XCNQ:BNXT) » Definitions » EPS (Diluted)

BioNxt Solutions (XCNQ:BNXT) EPS (Diluted) : C$-0.05 (TTM As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is BioNxt Solutions EPS (Diluted)?

BioNxt Solutions's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was C$-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.05.

BioNxt Solutions's EPS (Basic) for the three months ended in Mar. 2024 was C$-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.05.

BioNxt Solutions's EPS without NRI for the three months ended in Mar. 2024 was C$-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was C$-0.05.

During the past 3 years, the average EPS without NRIGrowth Rate was 33.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was -16.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, BioNxt Solutions's highest 3-Year average EPS without NRI Growth Rate was 33.30% per year. The lowest was -136.10% per year. And the median was 18.80% per year.


BioNxt Solutions EPS (Diluted) Historical Data

The historical data trend for BioNxt Solutions's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNxt Solutions EPS (Diluted) Chart

BioNxt Solutions Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial -0.17 -0.30 -0.29 -0.15 -0.08

BioNxt Solutions Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.09 -0.02 -0.01 -0.03 -0.01

Competitive Comparison of BioNxt Solutions's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, BioNxt Solutions's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNxt Solutions's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioNxt Solutions's PE Ratio distribution charts can be found below:

* The bar in red indicates where BioNxt Solutions's PE Ratio falls into.



BioNxt Solutions EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

BioNxt Solutions's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-7.723-0)/99.323
=-0.08

BioNxt Solutions's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.574-0)/108.987
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNxt Solutions  (XCNQ:BNXT) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


BioNxt Solutions EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of BioNxt Solutions's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNxt Solutions (XCNQ:BNXT) Business Description

Traded in Other Exchanges
Address
1820 Fir Street, Suite 270, Vancouver, BC, CAN, V6J 3B1
BioNxt Solutions Inc is a cannabis company engaged in developing analytical testing, processing, and formulation capability in Canada. It is also engaged in research, cultivation, extraction, import, distribution, and manufacturing in Germany. The products of the company include Drug Delivery, Point-of-Care Diagnostics, and Psychedelics.

BioNxt Solutions (XCNQ:BNXT) Headlines

No Headlines